| User's Publication |
|
16215
Manami Suzuki-Karasaki, Takashi Ando, Yushi Ochiai, Kenta Kawahara, Miki Suzuki-Karasaki, Hideki Nakayama, Yoshihiro Suzuki-Karasaki
Air Plasma-Activated Medium Evokes a Death-Associated Perinuclear Mitochondrial Clustering
Int J Mol Sci
2022
23(3):1124
PubMed ID: 35163042
DOI: 10.3390/ijms23031124
|
|
16415
Kuriyama S, Tanaka G, Takagane K, Itoh G, Tanaka M.
Pigment Epithelium Derived Factor Is Involved in the Late Phase of Osteosarcoma Metastasis by Increasing Extravasation and Cell-Cell Adhesion
Front Oncol
2022
12:818182
PubMed ID: 35174090
DOI: 10.3389/fonc.2022.818182
|
|
20751
Wada KI, Hosokawa K, Ito Y, Maeda M, Harada Y, Yonemitsu Y.
Generation of transmitochondrial cybrids using a microfluidic device.
Exp Cell Res
2022
418(1):113233
PubMed ID: 35659971
DOI: 10.1016/j.yexcr.2022.113233
|
|
16389
Ideta H, Yoshida K, Okamoto M, Sasaki J, Kito M, Aoki K, Yoshimura Y, Suzuki S, Tanaka A, Takazawa A, Haniu H, Uemura T, Takizawa T, Sobajima A, Kamanaka T, Takahashi J, Kato H, Saito N.
Antitumor Effect of Sclerostin against Osteosarcoma
Cancers (Basel)
2021
13(23):6015
PubMed ID: 34885123
DOI: 10.3390/cancers13236015
|
|
16865
Ando T, Suzuki-Karasaki M, Suzuki-Karasaki M, Ichikawa J, Ochiai T, Yoshida Y, Haro H, Suzuki-Karasaki Y.
Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology
Front Oncol
2021
11:593127
PubMed ID: 34150606
DOI: 10.3389/fonc.2021.593127
|
|
11888
Yoshida K, Okamoto M, Sasaki J, Kuroda C, Ishida H, Ueda K, Ideta H, Kamanaka T, Sobajima A, Takizawa T, Tanaka M, Aoki K, Uemura T, Kato H, Haniu H, Saito N.
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
BMC Cancer
2020
20(1):25.
PubMed ID: 31914969
DOI: 10.1186/s12885-019-6499-y
|
|
11888
Yoshida K, Okamoto M, Sasaki J, Kuroda C, Ishida H, Ueda K, Ideta H, Kamanaka T, Sobajima A, Takizawa T, Tanaka M, Aoki K, Uemura T, Kato H, Haniu H, Saito N.
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells.
BMC Cancer
2020
20(1):25.
PubMed ID: 31914969
DOI: 10.1186/s12885-019-6499-y
|
|
13141
Oka N, Komuro A, Amano H, Dash S, Honda M, Ota K, Nishimura S, Ueda T, Akagi M, Okada H.
Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin.
Pharmacol Res Perspect
2020
PubMed ID: 32725721
DOI: 10.1002/prp2.632
|
|
13306
Ando T, Ichikawa J, Fujimaki T, Taniguchi N, Takayama Y, Haro H.
Gemcitabine and Rapamycin Exhibit Additive Effect against Osteosarcoma by Targeting Autophagy and Apoptosis.
Cancers (Basel)
2020
PubMed ID: 33114161
DOI: 10.3390/cancers12113097
|
|
11978
Asano N, Takeshima H, Yamashita S, Takamatsu H, Hattori N, Kubo T, Yoshida A, Kobayashi E, Nakayama R, Matsumoto M, Nakamura M, Ichikawa H, Kawai A, Kondo T, Ushijima T.
Epigenetic reprogramming underlies efficacy of DNA demethylation therapy in osteosarcomas.
Sci Rep
2019
PubMed ID: 31889115
DOI: 10.1038/s41598-019-56883-0
|
|
9465
Tomohiko Tokunaga, Takashi Ando, Miki Suzuki-Karasaki, Tomohisa Ito, Asuka Onoe-Takahashi, Toyoko Ochiai, Masayoshi Soma , Yoshihiro Suzuki-Karasaki
Plasma-stimulated Medium Kills TRAIL-resistant Human Malignant Cells by Promoting Caspase-Independent Cell Death via Membrane Potential and Calcium Dynamics Modulation
Int J Oncol
2018
52(3):697-708
PubMed ID: 29393427
DOI: 10.3892/ijo.2018.4251
|
|
14766
Wada KI, Hosokawa K, Ito Y, Maeda M.
Quantitative control of mitochondria transfer between live single cells using a microfluidic device
Biol Open
2017
6(12):1960-1965
PubMed ID: 29092814
DOI: 10.1242/bio.024869
|
|
10919
Antitumor activities of BIBF 1120, BI 860585, and BI 836845 in preclinical models of sarcoma
Integr Mol Med
2016
3: 755-760
DOI: 10.15761/IMM.1000239
|
|
16938
Odagiri H, Kadomatsu T, Endo M, Masuda T, Morioka MS, Fukuhara S, Miyamoto T, Kobayashi E, Miyata K, Aoi J, Horiguchi H, Nishimura N, Terada K, Yakushiji T, Manabe I, Mochizuki N, Mizuta H, Oike Y.
The secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells through integrin α5β1, p38 MAPK, and matrix metalloproteinases
Sci Signal
2014
7(309):ra7
PubMed ID: 24448647
DOI: 10.1126/scisignal.2004612
|
|
8566
Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, Araki N, Kudawara I, Ieguchi M, Nakamura K, Nakamura Y, Matsuda K.
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma.
Cancer Sci.
2009
100:1227-33
PubMed ID: 19486338
DOI: 10.1111/j.1349-7006.2009.01165.x
|
|
9072
M Saijo, T Suzutani, K Mizuta, I Kurane, S Morikawa
Characterization and Susceptibility to Antiviral Agents of Herpes Simplex Virus Type 1 Containing a Unique Thymidine Kinase Gene With an Amber Codon Between the First and the Second Initiation Codons
Arch Virol
2008
153 (2), 303-14
PubMed ID: 18066636
DOI: 10.1007/s00705-007-1096-9
|
|
9041
Tatsuo Suzutani, Ken Ishioka, Erik De Clercq, Kei Ishibashi, Hisatoshi Kaneko, Toshihiko Kira, Koh-Ichi Hashimoto, Masahiro Ogasawara, Katsuki Ohtani, Nobutaka Wakamiya, Masayuki Saijo
Differential Mutation Patterns in Thymidine Kinase and DNA Polymerase Genes of Herpes Simplex Virus Type 1 Clones Passaged in the Presence of Acyclovir or Penciclovir
Antimicrob Agents Chemother
2003
47 (5), 1707-13
PubMed ID: 12709344
DOI: 10.1128/aac.47.5.1707-1713.2003
|
|
9034
Masayuki Saijo, Tatsuo Suzutani, Erik De Clercq, Masahiro Niikura, Akihiko Maeda, Shigeru Morikawa, Ichiro Kurane
Genotypic and Phenotypic Characterization of the Thymidine Kinase of ACV-resistant HSV-1 Derived From an Acyclovir-Sensitive Herpes Simplex Virus Type 1 Strain
Antiviral Res
2002
56 (3), 253-62
PubMed ID: 12406508
DOI: 10.1016/s0166-3542(02)00131-6
|
Back
Top
CELL BANK Website
